CAS: 477600-75-2 - Tofacitinib

Formel: C₁₆H₂₀N₆O

InChl: InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1

InChI Key: InChIKey=UJLAWZDWDVHWOW-YPMHNXCESA-N

SMILES: N#CCC(=O)N1CCC(C)C(N(C=2N=CN=C3NC=CC32)C)C1

Synonyme:

• (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
• 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
• 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
• 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-
• 3-{(3S,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
• Cp 690550
• Tofacitinib

3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile

CAS: 477600-75-2

• Formel: C₁₆H₂₀N₆O
• Reinheit: 97%
• Farbe und Form: Solid
• Molekulargewicht: 312.3696

Tofacitinib Citrate

CAS: 477600-75-2540737-29-9

• Formel: C₁₆H₂₀N₆O·C₆H₈O₇
• Farbe und Form: White To Off-White Solid
• Molekulargewicht: 312.38 192.12

Tofacitinib

CAS: 477600-75-2

• Formel: C₁₆H₂₀N₆O
• Reinheit: ≥ 98.0%
• Farbe und Form: White to off-white solid
• Molekulargewicht: 312.37

Tofacitinib

CAS: 477600-75-2

Tofacitinib (Tasocitinib) is an orally Janus kinase inhibitor. Tofacitinib is used for the treatment of …

• Formel: C₁₆H₂₀N₆O
• Reinheit: 100% - 99.71%
• Farbe und Form: Solid
• Molekulargewicht: 312.37

Tofacitinib

CAS: 477600-75-2

JAK3 enzyme inhibitor

• Formel: C₁₆H₂₀N₆O
• Reinheit: Min. 98 Area-%
• Farbe und Form: Powder
• Molekulargewicht: 312.37 g/mol